| Patent application number | Description | Published |
|---|
| 20080214765 | GRAFTED POLYMERS AND METHODS OF MAKING AND USING THEREOF - Grafted polymers which are the reaction products of:
| 09-04-2008 |
| 20100317522 | Adjuvants for Agrochemical Applications - The invention is directed to an adjuvant composition for agrochemical formulations, the adjuvant composition comprising a salt of N-lauryl iminopropionic acid and an alkylamine derivative. Also provided is an agrochemical formulation, including an active agrochemical substance, a salt of N-lauryl iminopropionic acid, and an alkylamine derivative. Another aspect of the invention is directed to a method for making an adjuvant composition for an agrochemical formulation, including the steps of providing a salt of N-lauryl iminopropionic acid, and combining the salt of N-lauryl iminopropionic acid with an alkylamine derivative. | 12-16-2010 |
| 20100323891 | Biocide Compositions (I) - The invention relates to biocide compositions, comprising (a) at least one dialkylamide based on a hydroxycarboxylic acid, and (b) at least one biocide. The compositions exhibit an improved stability even if stored at temperatures between 5° and 40° C. over an extended period. | 12-23-2010 |
| 20100323898 | Biocide Compositions (II) - The invention relates to biocide compositions, comprising (a) at least one dialkylamide based on oleic and/or linoleic acid, and (b) at least one biocide. The compositions exhibit an improved stability even if stored at temperatures between 5° and 40° C. for an extended period. | 12-23-2010 |
| 20100331185 | Herbicidal Compositions of Lithium Glyphosate and Adjuvants - Disclosed are herbicidal compositions comprising a lithium salt of glyphosate and one or more surfactants, the surfactant(s) enhancing the herbicidal efficacy of the lithium salt of glyphosate over that of the lithium salt of glyphosate alone. | 12-30-2010 |
| 20110082037 | Adjuvant Compositions - The invention is directed to adjuvant compositions, comprising (a) alk(en)yl oligoglycoside alkoxylates, and (b) primary alcohol alkoxylates. The compositions exhibit improved adjuvant activity for biocides in general, and glyphosate in particular. They are environmentally safe, show high cold water miscibility and low foam behaviour. | 04-07-2011 |
| 20110226164 | Defoamers - The invention is direct to ethoxylated/propoxylated fatty alcohol (meth)acrylates according to general formula (I) , | 09-22-2011 |
| Patent application number | Description | Published |
|---|
| 20090011985 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 01-08-2009 |
| 20090088383 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 04-02-2009 |
| 20100087366 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 04-08-2010 |
| 20110105390 | SELECTION AND TREATMENT OF PATIENTS SUFFERING FROM WASTING - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions. | 05-05-2011 |
| 20120004174 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 01-05-2012 |
